Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,569 | 1,751 | 2,120 | 717 | 1,182 |
| Receivables | 6 | 301 | N/A | N/A | N/A |
| TOTAL | $1,602 | $2,118 | $2,228 | $1,007 | $1,220 |
| Non-Current Assets | |||||
| PPE Net | 18 | 27 | 37 | 48 | 64 |
| Other Non-Current Assets | 16 | 16 | 16 | 16 | 16 |
| TOTAL | $34 | $43 | $53 | $65 | $80 |
| Total Assets | $1,636 | $2,160 | $2,281 | $1,072 | $1,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 2,685 | 2,454 |
| Accounts payable and accrued liabilities | 131 | 148 | 185 | 409 | 250 |
| TOTAL | $131 | $148 | $185 | $3,094 | $2,704 |
| Non-Current Liabilities | |||||
| TOTAL | $625 | $680 | $394 | $408 | $422 |
| Total Liabilities | $756 | $828 | $579 | $3,502 | $3,126 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,811 | 17,811 | 17,795 | 17,775 | 13,655 |
| Common Shares | 38,706 | 38,706 | 38,634 | 32,858 | 32,865 |
| Retained earnings | -37,919 | -37,467 | -37,025 | -35,382 | -34,784 |
| TOTAL | $880 | $1,333 | $1,702 | $-2,431 | $-1,826 |
| Total Liabilities And Equity | $1,636 | $2,160 | $2,281 | $1,072 | $1,300 |